Search

everythinglearnresearchcommunity

for

Search:↓

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

New compounds show promise as nonsteroidal treatments for hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Herbal stimulants in Cerita hair tonic can significantly reduce hair loss and the side effects of Minoxidil 1%.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Two new compounds were found to effectively reduce hair growth in mice.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

New compounds may help treat prostate issues without affecting androgen receptors.